Affiliated Sites
  • Clinicians Network Payer Bioinformatics
Be The Match

Javascript disabled. This site requires JavaScript How to enable JavaScript.

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close

NMDP

Be The Match
  • About Us
  • E-News Sign Up
  • My Cart
  • Transplant Indications and Outcomes
    • HLA Today
    • Disease-Specific Indications and Outcomes
      • AML - Adult
      • AML - Pediatric
      • ALL - Adult
      • ALL - Pediatric
      • MDS
      • CML
      • CLL
      • NHL
      • Hodgkin Lymphoma
      • Multiple Myeloma
      • Severe Aplastic Anemia & Marrow Failure
      • Sickle Cell Disease
      • Immune Deficiency Diseases
      • Inherited Metabolic Disorders
      • Thalassemia
      • Other Diseases
      • Myeloproliferative Neoplasms
    • Additional Outcomes
      • Unrelated vs. Sibling Donor Outcomes
      • Older Patient Outcomes
      • Timing Impact on Outcomes
    • Eligibility
    • Referral Timing Guidelines
    • Order Kits
    • HLA Typing for Family Members
  • Transplant Therapy and Donor Matching
    • Cell Sources
    • HLA Typing and Matching
    • Donor or Cord Blood Search Process
      • Likelihood of Finding a Match
      • Preliminary Search Request
    • Jason Carter Clinical Trials Program
  • Post-Transplant Care
    • Early Complications
    • Vaccinations
    • Long-Term Care Guidelines
      • Pediatric Considerations
    • Chronic GVHD
      • Skin
      • Nails
      • Scalp and Body Hair
      • Eyes
      • Mouth
      • Lungs
      • Muscles, Fascia, Joints
      • Hematopoietic & Immune
      • GI Tract
      • Liver
      • Genitalia
      • Other
    • Post-Transplant Guidelines
  • Medical Education & Research
    • Browse News
    • Browse Research
      • Mismatched donor sources may fill an unmet need for patients without fully matched family or unrelated donors
      • Hematopoietic cell donor type may not impact quality of life post-transplant
      • Novel three-drug combination improves GVHD-free and relapse-free survival and relapse after allogeneic transplant
      • Long-term risks of hematological malignancy, autoimmune or thrombotic events do not differ in bone marrow and filgrastim-mobilized PBSC donors
      • Socioeconomic status but not race and ethnicity is likely associated with chronic GVHD outcomes after allogeneic HCT
      • Linkage across research databases may provide a more complete understanding of HCT patient outcomes
      • Race and ethnicity matching may not impact umbilical cord blood transplant patient outcomes
    • Education Catalog
      • Predicting and Addressing Relapse After HCT
      • After the Results Quality of Life Pre- and Post-Transplant
    • Materials Catalog
    • HCT Presentation Slides
    • About Our Research
    • Transplant Enews
  • Resources
    • Patient Resources
    • Financial Resources
    • Obstetrician Resources
    • Technique Videos
    • Umbilical Cord Blood Collection Training for Public Donation
    • Local Provider Partnership Program

  • Email
  • Print This Page

Curriculum Modules and Videos

We are currently experiencing video playback errors and are working with IT Services to reconcile the problem. Thank you for your patience.

View the Blood and Marrow Transplantation (BMT) curriculum modules and videos below.

Complete Post-Curriculum Survey After Viewing Modules

After viewing the modules, please complete a short survey. Your feedback is very important to us, whether or not you have viewed all of the modules. Access post-curriculum survey. 

For those participating in a BMT elective rotation, you will receive a certificate to provide to your program administrator after you complete the post-curriculum survey. 

Didactic Curriculum Modules

  • History and evolution of HCT; Spanish transcript (PDF)
    Rainer Storb, M.D. - Fred Hutchinson Cancer Research Center
  • Biology of stem cells and use for transplantation; Spanish transcript (PDF)
    Hal Broxmeyer, M.D. - Indiana University School of Medicine
  • Types of Hematopoietic Stem Cell Transplants and Their Preparative Regimens; Spanish transcript (PDF)
    George Selby, M.D. - University of Oklahoma
  • HLA typing and donor selection; Spanish transcript (PDF)
    Ann Woolfrey, M.D. - Seattle Cancer Center Alliance
  • Early complications of BMT; Spanish transcript (PDF)
    Miguel-Angel Perales, M.D. - Memorial Sloan-Kettering Cancer Center
  • Late complications of BMT including infections and organ complications; Spanish transcript (PDF)
    Linda Burns, M.D. - University of Minnesota
  • Graft-versus-host disease; Spanish transcript (PDF)
    Eneida Nemecek, M.D. - Oregon Health & Science University
  • Transfusion therapy; Spanish transcript (PDF)
    Ed Snyder, M.D. - Yale University of Medicine
  • Lymphoid malignancies and transplant; Spanish transcript (PDF)
    Christopher Flowers, M.D. - Emory University School of Medicine
  • Chronic myeloid malignancies and transplantation; Spanish transcript (PDF)
    Corey Cutler, M.D., NPH, FRCP(C) - Harvard Medical School Dana-Farber Cancer Institute
  • Acute leukemias and transplant (adult); Spanish transcript (PDF)
    Mark Litzow, M.D. - Mayo Clinic
  • Multiple Myeloma and Hematopoietic Cell Transplantation
    Shaji Kumar, M.D. - Mayo Clinic
  • Pediatric leukemias and HCT; Spanish transcript (PDF)
    Nancy Bunin, M.D. - The Children's Hospital of Philadelphia
  • Stem cell transplant for non-malignant disorders; Spanish transcript (PDF)
    Shalini Shenoy, M.D. - St. Louis Children's Hospital
  • Pediatric solid tumors and transplantation; Spanish transcript (PDF)
    Shakila Khan, M.D., and Julia Gourde, C.N.P. - Mayo Clinic
  • The future of transplant; Spanish transcript (PDF)
    Helen Heslop, M.D. - Baylor College of Medicine
  • Molding a career in BMT
    Evan Shereck, M.D. - Oregon Health & Science University

Why I chose the field of HCT videos

View these short videos to learn what pioneers and leading transplant physicians have to say about BMT.

John Koreth, M.B.B.S., D.Phil

Dr. Koreth explains what he finds exciting about BMT and shares advice for those considering this field. View video.
Medical onocologist, Dana-Farber Cancer Institute; Instructor, Harvard Medical School, Boston, MA
Expertise:  Stem cell/BMT, Leukemia, Lymphoma, Myelodysplasic, Multiple myeloma

Stephanie Lee, M.D., M.P.H.

Dr. Lee describes why she recommends a career in BMT. View video.
Member, Fred Hutchinson Cancer Research Center Professor of Medical Oncology, University of Washington School of Medicine, Seattle, WA
Expertise: Allogeneic HCT, chronic GVHD, outcomes and health services research

Eliane Gluckman, M.D., FRCP

Dr. Gluckman explains how she became interested in BMT. View video. She also describes the first cord blood transplant. View video.
Professor Emeritus in Hematology Department of Hematology, Hôpital St Louis, Paris, France, Head of Eurocord
Expertise: Cord blood transplant, performed first successful cord blood transplant 

Rainer Storb, M.D.

Dr. Storb shares his interest in translating laboratory research into the clinic and the joy of meeting past patients. View video.
Head & Member, Transplantation Biology Program, Fred Hutchinson Cancer Research Center; Professor of Medicine, University of Washington
Expertise: HCT, nonmyeloablative transplant conditioning, GVHD, aplastic anemia

  • Email
  • Print This Page

Slides may be downloaded and used without permission for one-time presentation or personal use.  For publication, use in print or web, or repeated presentations, please submit a Copyright Request Form.

Transplant Indications and Outcomes

  • HLA Today
  • Disease-Specific Indications and Outcomes
  • Additional Outcomes
  • Eligibility
  • Referral Timing Guidelines
  • Order Kits
  • HLA Typing for Family Members

Transplant Therapy and Donor Matching

  • Cell Sources
  • HLA Typing and Matching
  • Donor or Cord Blood Search Process
  • Jason Carter Clinical Trials Program

Resources

  • Patient Resources
  • Financial Resources
  • Obstetrician Resources
  • Technique Videos
  • Umbilical Cord Blood Collection Training for Public Donation
  • Local Provider Partnership Program

Contact Us

About Us

Our Websites

bethematch.org
BeTheMatch.org Information and support for patients, donors and supporters of our mission.
BeTheMatchBioTherapies.com
BeTheMatchBioTherapies.com Proven solutions for organizations developing and delivering new cellular therapies
CIBMTR.org
CIBMTR.org Transplant research, clinical studies, publications and outcomes data for researchers and clinicians.
National Marrow Donor Program —
Entrusted and under contract to operate the C.W. Bill Young Cell Transplantation Program, including Be The Match Registry®.
Copyright © 1996-2023 National Marrow Donor Program. All Rights Reserved. Terms of Use | Privacy Policy | Trademark & Copyright